Answers are grounded in this paper and cite their sources.
Evaluation of new vaccines against tuberculosis requires diagnostic tools for accurately identifying asymptomatic individuals infected with Mycobacterium tuberculosis and persons with active tuberculosis. This article discusses limitations of current methods for the immunologic diagnosis of latent infection and active disease and presents novel approaches to developing skin tests and serodiagnostic assays based on "cocktails" of multiple antigens of M. tuberculosis.
No takes yet. Share an insight, caveat, or question.
Maria Laura Gennaro (2000) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: